Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2026-02-20 @ 3:54 PM
Study NCT ID:
NCT04492618
Status:
COMPLETED
Last Update Posted:
2023-02-08
First Post:
2020-07-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica
Sponsor:
Aaron R. Mangold
Organization:
Study Overview
Official Title:
Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica
Status:
COMPLETED
Status Verified Date:
2023-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This research study is evaluating the safety and efficacy of a topical drug treatment "Ruxolitinib" in treating Necrobiosis Lipoidica (NL).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: